ConductScience.org, home

Paper17954373

Integrins: molecular determinants of glioma invasion.

D'Abaco GM and 1 other. J Clin Neurosci, 2007. Cited by 115 papers, by iCite.

Cite this record

ConductScience Library. Integrins: molecular determinants of glioma invasion. Papers, record 17954373. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17954373

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Integrins: molecular determinants of glioma invasion.
PubMed
Journal
J Clin Neurosci
PubMed
Year
2007
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
115
iCite
Relative citation ratio, by iCite
2.51
iCite
Revised in PubMed
2007-10-23
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1D'Abaco GMGiovanna M
2Kaye AHAndrew H

Source PubMed

Download CSV of authors

Topics5

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Brain NeoplasmsMajor topic
GliomaMajor topic
IntegrinsMajor topic
Humans
Neoplasm Invasiveness

Cited by57

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 115 citations.

PMIDTitleJournalYearIn PapersSource
41595739The Extracellular Matrix, the Silent 'Architect' of Glioma.Biomedicines2026https://conductscience.org/library/papers/41595739PubMed
41210309Diamond Nanoparticles Suppress Migration of T98G Glioblastoma Cells by Targeting ECM-Integrin Interactions and Intracellular Signaling, Leading to Extensive Proteome Alterations.Nanotechnol Sci Appl2025https://conductscience.org/library/papers/41210309PubMed
40863857Dynamic Susceptibility Contrast Magnetic Resonance Imaging with Carbon-Encapsulated Iron Nanoparticles Navigated to Integrin Alfa V Beta 3 Receptors in Rat Glioma.Nanomaterials (Basel)2025https://conductscience.org/library/papers/40863857PubMed
40585979Immuno-oncological interactions between meningeal lymphatics and glioblastoma: from mechanisms to therapies.Theranostics2025https://conductscience.org/library/papers/40585979PubMed
40512281Clinical utility of GAL-8, ITGΒ-1, and HIF-1α as non-invasive diagnostic and prognostic biomarkers for assessing glioma.J Neurooncol2025https://conductscience.org/library/papers/40512281PubMed
40321805Carbon-Encapsulated Iron Nanoparticles Seeking Integrins in Murine Glioma.Int J Nanomedicine2025https://conductscience.org/library/papers/40321805PubMed
39972389Spatial analysis of a complete DIPG-infiltrated brainstem reveals novel ligand-receptor mediators of tumour-to-TME crosstalk.Acta Neuropathol Commun2025https://conductscience.org/library/papers/39972389PubMed
39876060Extension of T2 Hyperintense Areas in Patients With a Glioma: A Comparison Between High-Quality 7 T MRI and Clinical Scans.NMR Biomed2025https://conductscience.org/library/papers/39876060PubMed
39866225EMP2 promotes hepatocellular carcinoma proliferation and invasion by activating cellular autophagy.Oncol Res2025https://conductscience.org/library/papers/39866225PubMed
39595920Prognostic Role of Invasion-Related Extracellular Matrix Molecules in Diffusely Infiltrating Grade 2 and 3 Astrocytomas.Brain Sci2024https://conductscience.org/library/papers/39595920PubMed
37835499Effect of Dimeric Disintegrins Isolated from Vipera lebetina obtusa Venom on Glioblastoma Cellular Responses.Cancers (Basel)2023https://conductscience.org/library/papers/37835499PubMed
36187469Pathophysiological roles of integrins in gliomas from the perspective of glioma stem cells.Front Cell Dev Biol2022https://conductscience.org/library/papers/36187469PubMed
35631639Integrin-αvβ3 as a Therapeutic Target in Glioblastoma: Back to the Future?Pharmaceutics2022https://conductscience.org/library/papers/35631639PubMed
35527815Separating Glioma Hyperintensities From White Matter by Diffusion-Weighted Imaging With Spherical Tensor Encoding.Front Neurosci2022https://conductscience.org/library/papers/35527815PubMed
34771696Galectins in Glioma: Current Roles in Cancer Progression and Future Directions for Improving Treatment.Cancers (Basel)2021https://conductscience.org/library/papers/34771696PubMed
34067658The Multifunctional Role of EMP3 in the Regulation of Membrane Receptors Associated with IDH-Wild-Type Glioblastoma.Int J Mol Sci2021https://conductscience.org/library/papers/34067658PubMed
33966944Feasibility and clinical usefulness of modelling glioblastoma migration in adjuvant radiotherapy.Z Med Phys2022https://conductscience.org/library/papers/33966944PubMed
33807786Integrin αvβ3 Engagement Regulates Glucose Metabolism and Migration through Focal Adhesion Kinase (FAK) and Protein Arginine Methyltransferase 5 (PRMT5) in Glioblastoma Cells.Cancers (Basel)2021https://conductscience.org/library/papers/33807786PubMed
32490210Gene expression of Epithelial Membrane Protein 2 gene and β1-Integrin gene in patients with breast cancer.Biochem Biophys Rep2020https://conductscience.org/library/papers/32490210PubMed
31986121Autocrine CXCL8-dependent invasiveness triggers modulation of actin cytoskeletal network and cell dynamics.Aging (Albany NY)2020https://conductscience.org/library/papers/31986121PubMed

See all 57 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/17954373

GET https://conductscience.org/api/papers/v1/17954373/cited_by?page=2